Comment on: Cardiac fat pat change after laparoscopic sleeve gastrectomy and Roux-en-Y gastric bypass surgery: a systematic review and meta-analysis

Obesity is considered a severe public health problem and poses significant challenges due to its high prevalence rates. It is a condition that increases health costs from related diseases, particularly nontransmissible chronic diseases. Among the treatments for obesity, dietary and lifestyle changes are the most frequently used approaches as a first-access treatment. However, such interventions are ineffective in that they frequently do not achieve a 5%–10% reduction in weight at the start of treatment [ ]. Much attention has been paid to the unsuccessful disease control rates—we seem to be “paddling against the tide.” The cohort study carried out by Fildes et al. [ ] in the United Kingdom, which followed 278,982 participants for 10 years, found that the chance of people with obesity based on a body mass index (BMI) >30 kg/m² of being able to return to “normal” in 1 year is <1%. Most interestingly, just 1 in 12 men and 1 in 10 women can reduce 5% of body weight annually. The successful taxes are inverted proportionally with an increase in BMI. Such results show that the success rate for circumventing this public health problem is minimal. In this sense, bariatric surgery is the most effective treatment for patients with obesity who meet the criteria established by the American Society for Metabolic and Bariatric Surgery (ASMBS). Over the years, several studies have been published demonstrating the benefits of bariatric surgery to achieve success rates for treating obesity. Bariatric surgery is the “gold standard” treatment for weight loss in persons with severe obesity (BMI ≥35 kg/m²) in a short period and with long-term durability [ ].